Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy

NCT04826328 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain, Postoperative
Bunion

Interventions

DRUG: FX301
DRUG: Normal Saline

Sponsor

Pacira Pharmaceuticals, Inc

Collaborators

[object Object]